Recently, animal studies demonstrating the stromal PR-dependent antitumor effects provide a mechanistic link between progesterone action and endometrial dysfunction, in particular the development of endometrial carcinoma [46]. The gene discussed is PGR; the disease is endometrial carcinoma.